Benjamin F. Edwards & Company, Inc. Boston Scientific Corp Transaction History

Benjamin F. Edwards & Company, Inc.

$5.69 Billion
Q2 2024

A detailed history of Benjamin F. Edwards & Company, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 13,347 shares of BSX stock, worth $1.13 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

13,347

Previous 13,256 0.69%

Holding current value

$1.13 Million

Previous $908,000 13.22%

% of portfolio

0.02%

Previous 0.02%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$67.33 - $77.71 $6,127 - $7,071	91 Added 0.69%	13,347 $1.03 Million
Q1 2024 Apr 29, 2024	SELL	$57.6 - $68.62 $4,838 - $5,764	-84 Reduced 0.63%	13,256 $908,000
Q4 2023 Feb 06, 2024	BUY	$48.64 - $57.81 $96,647 - $114,868	1,987 Added 17.5%	13,340 $771,000
Q3 2023 Nov 13, 2023	BUY	$50.19 - $54.68 $96,063 - $104,657	1,914 Added 20.28%	11,353 $599,000
Q1 2023 Apr 27, 2023	SELL	$45.09 - $50.03 $135 - $150	-3 Reduced 0.03%	9,439 $472,000
Q4 2022 Feb 07, 2023	SELL	$39.56 - $47.22 $356 - $424	-9 Reduced 0.1%	9,442 $437,000
Q3 2022 Oct 28, 2022	SELL	$36.71 - $109.66 $14,206 - $42,438	-387 Reduced 3.93%	9,451 $366,000
Q2 2022 Aug 12, 2022	SELL	$35.24 - $47.1 $5,145 - $6,876	-146 Reduced 1.46%	9,838 $367,000
Q1 2022 May 04, 2022	SELL	$40.9 - $45.1 $29,529 - $32,562	-722 Reduced 6.74%	9,984 $442,000
Q4 2021 Feb 07, 2022	SELL	$38.07 - $44.87 $7,157 - $8,435	-188 Reduced 1.73%	10,706 $455,000
Q2 2021 Aug 11, 2021	SELL	$38.58 - $44.24 $347 - $398	-9 Reduced 0.08%	10,894 $466,000
Q1 2021 May 14, 2021	BUY	$35.27 - $39.67 $25,006 - $28,126	709 Added 6.96%	10,903 $421,000
Q4 2020 Feb 16, 2021	SELL	$33.15 - $41.97 $5,536 - $7,008	-167 Reduced 1.61%	10,194 $366,000
Q3 2020 Nov 13, 2020	BUY	$34.44 - $42.23 $78,626 - $96,411	2,283 Added 28.26%	10,361 $396,000
Q2 2020 Aug 14, 2020	SELL	$30.19 - $39.11 $2,475 - $3,207	-82 Reduced 1.0%	8,078 $284,000
Q1 2020 May 07, 2020	BUY	$25.83 - $45.71 $19,295 - $34,145	747 Added 10.08%	8,160 $266,000
Q4 2019 Feb 06, 2020	BUY	$37.87 - $45.37 $1,779 - $2,132	47 Added 0.64%	7,413 $335,000
Q3 2019 Nov 05, 2019	SELL	$40.31 - $43.45 $1,209 - $1,303	-30 Reduced 0.41%	7,366 $300,000
Q2 2019 Aug 08, 2019	BUY	$34.91 - $42.98 $16,756 - $20,630	480 Added 6.94%	7,396 $318,000
Q1 2019 May 15, 2019	BUY	$32.91 - $40.75 $9,872 - $12,225	300 Added 4.53%	6,916 $265,000
Q4 2018 Jan 31, 2019	BUY	$31.73 - $39.04 $76,310 - $93,891	2,405 Added 57.11%	6,616 $234,000
Q3 2018 Oct 29, 2018	BUY	$32.83 - $38.63 $128,398 - $151,081	3,911 Added 1303.67%	4,211 $162,000
Q2 2018 Jul 19, 2018	SELL	$26.84 - $34.32 $10,736 - $13,728	-400 Reduced 57.14%	300 $10,000
Q1 2018 Apr 17, 2018	SELL	$25.2 - $28.54 $15,120 - $17,124	-600 Reduced 46.15%	700 $19,000
Q4 2017 Jan 17, 2018	BUY	$24.79 - $29.8 $24,690 - $29,680	996 Added 327.63%	1,300 $32,000
Q3 2017 Oct 24, 2017	BUY	$26.26 - $29.17 $7,983 - $8,867	304	304 $9,000

Others Institutions Holding BSX

# of Institutions

1,467

Shares Held

1.21B

Call Options Held

8.13M

Put Options Held

8.3M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $121B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.

Account

Benjamin F. Edwards & Company, Inc. Boston Scientific Corp Transaction History